Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,690 | 22,790 | -3,336 | -7,690 | -4,636 |
| Depreciation Amortization | 1,198 | 4,710 | 3,265 | 2,002 | 968 |
| Income taxes - deferred | 2,400 | 987 | 933 | -835 | 635 |
| Accounts receivable | 39,396 | -40,801 | -744 | 1,099 | 59 |
| Accounts payable and accrued liabilities | -1,868 | 7,105 | -475 | -6,464 | -2,294 |
| Other Working Capital | 14,946 | -32,990 | -19,786 | -10,436 | -15,250 |
| Other Operating Activity | -38,596 | 34,139 | 5,396 | 8,697 | 2,335 |
| Operating Cash Flow | $14,786 | $-4,060 | $-14,747 | $-13,627 | $-18,183 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,490 | -41,220 | -25,712 | -14,421 | -2,853 |
| Net Acquisitions | N/A | -210 | -218 | N/A | N/A |
| Other Investing Activity | 0 | -200 | -190 | 0 | 0 |
| Investing Cash Flow | $-16,490 | $-41,630 | $-26,120 | $-14,421 | $-2,853 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 32,430 | 35,853 | 8,500 | N/A |
| Debt Repayment | -9,386 | -1,569 | -11,290 | -814 | -192 |
| Common Stock Issued | 890 | 54,819 | 43 | 43 | 2 |
| Common Stock Repurchased | N/A | -192 | -221 | -201 | -200 |
| Other Financing Activity | 1,597 | 532 | 0 | 0 | 0 |
| Financing Cash Flow | $-6,899 | $86,020 | $24,385 | $7,528 | $-390 |
| Exchange Rate Effect | -170 | -190 | 94 | -37 | -94 |
| Beginning Cash Position | 76,418 | 36,290 | 36,294 | 36,294 | 36,294 |
| End Cash Position | 67,645 | 76,410 | 19,906 | 15,737 | 14,774 |
| Net Cash Flow | $-8,773 | $40,120 | $-16,388 | $-20,557 | $-21,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,786 | -4,060 | -14,747 | -13,627 | -18,183 |
| Capital Expenditure | -16,490 | -41,228 | -25,712 | -14,421 | -2,853 |
| Free Cash Flow | -1,704 | -45,288 | -40,459 | -28,048 | -21,036 |